Wednesday, December 6, 2023
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Associate Professor
Harvard Medical School
Vice Chair of Clinical Trials and Innovation
Director, Center for Skin and Related Musculoskeletal Diseases
Director, Clinical Unit for Research Innovation and Trials
Department of Dermatology and Department of Medicine
Division of Rheumatology
Brigham and Women's Hospital
Boston, Massachusetts
Assistant Professor of Medicine
Director, Yale Spondyloarthritis Program
Co-Chair, Quality and Safety Council, Rheumatology
Yale School of Medicine
New Haven, Connecticut
Clinical Professor
University of Washington School of Medicine
Director, Division of Rheumatology Research
Swedish Medical Center
Providence St. Joseph Health
Seattle, Washington
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
Physicians - maximum of 1.00 AMA PRA Category 1 Credit(s)™
This activity is intended for rheumatologists and other healthcare professionals who treat patients with SpA globally, including the United States.
The goal of this activity is for learners to be better able to select appropriate and individualized pharmacologic and nonpharmacologic interventions for patients with axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) with axial involvement.
Upon completion of this intervention, learners will have greater competence in:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Associate Professor
Harvard Medical School
Vice Chair of Clinical Trials and Innovation
Director, Center for Skin and Related Musculoskeletal Diseases
Director, Clinical Unit for Research Innovation and Trials
Department of Dermatology and Department of Medicine
Division of Rheumatology
Brigham and Women's Hospital
Boston, Massachusetts
Assistant Professor of Medicine
Director, Yale Spondyloarthritis Program
Co-Chair, Quality and Safety Council, Rheumatology
Yale School of Medicine
New Haven, Connecticut
Clinical Professor
University of Washington School of Medicine
Director, Division of Rheumatology Research
Swedish Medical Center
Providence St. Joseph Health
Seattle, Washington
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
Medscape, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME Released: 12/9/2022
Valid for credit through: 12/9/2023, 11:59 PM EST
processing....
